Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Leading biotech and pharmaceutical companies on the Fortune China 500 ranking 2020

According to the Fortune China 500 ranking in 2020, Shanghai Pharmaceuticals ranked first among all Chinese biotech and pharmaceutical companies, with an annual revenue of about 186.6 billion yuan in 2019. China Resources Pharmaceutical Group was the second placeholder with 180 billion yuan in annual revenue, followed by Guangzhou Baiyunshan Pharmaceutical with a wide margin. The ranking is based on total revenue in 2019 and was released in July 2020.

Brief overview of the industry

China was one of the pioneers of the medical and healthcare industry in the Asia-Pacific region, especially in the fields of pharmaceuticals and biotechnology. The Chinese pharmaceuticals industry had registered promising growth in recent years, mainly due to favourable market regulation policies which had broadened the market access of patented drugs. The leading pharmaceutical manufacturer, Shanghai Pharmaceuticals, registered significant growth in revenue in the last decade. Its rise has been aided by the faster approval process of new drugs, overseas market expansion and a collective industry movement towards innovative products.

The role of traditional Chinese medicine (TCM)

With over 3000 years of history, the Chinese tradition of using animal and herbal extracts for treatment is gaining gradual popularity among its western counterparts. Guangzhou Baiyunshan Pharmaceuticals, Yunnan Baiyao Group, and Beijing Tong Reng Tang are the prominent TCM manufacturers with considerable gross profits. The traditional Chinese medicine industry has received progressive assistance from government initiatives to improve industry standards and efficiency in the production of traditional medicine. In the COVID-19 pandemic, TCM also played an important role as a measure to boost public immunity.

Leading Chinese biotech and pharmaceutical companies on the Fortune China 500 ranking in 2020, by revenue

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until March 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

July 2020

Region

China

Survey time period

2019

Supplementary notes

Figures refer to annual revenues in 2019 and have been rounded for a better understanding.

Note: 1 yuan is equal to approximately 0.14 U.S. dollars and 0.12 euros (as of August 2020).

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Pharmaceutical industry in China"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.